/FSPKF

FSPKF Stock - Fisher & Paykel Healthcare Corporation Limited

Q: What is the analyst price target for FSPKF?

Analyst price target information is not currently available for FSPKF.

Q: What is FSPKF's market cap?

Market capitalization information is not currently available for FSPKF.

Healthcare|Medical - Instruments & Supplies|OTC

$21.92-8.67%

$2.08 (-8.67%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+6.9%upside

Target: $23.43

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for FSPKF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.90

52W High$25.91

52W Low$16.35

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$1.28B	$1.76B	$1.59B	$1.64B	$1.95B
Gross Profit	$530.20M	$1.06B	$945.90M	$1.01B	$1.22B
Gross Margin	41.4%	60.3%	59.5%	61.7%	62.8%
Operating Income	$-371,000,000	$254.40M	$334.70M	$509.10M	$723.20M
Net Income	$377.20M	$132.60M	$250.30M	$376.90M	$524.20M
Net Margin	29.5%	7.5%	15.8%	22.9%	26.9%
EPS	$0.64	$0.23	$0.43	$0.65	$0.91

Company Overview

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Visit Website

Earnings History & Surprises

FSPKF

Beat Rate

67%

Last 12 quarters

Avg Surprise

-1.1%

EPS vs Estimate

Beats / Misses

8/4

Last 12 quarters

Latest EPS

$0.12

Q4 2025

EPS Surprise History

Q1 22

+4.0%

$0.19vs$0.18

Q3 22

+5.2%

$0.09vs$0.09

Q1 23

+0.9%

$0.17vs$0.16

Q3 23

+4.3%

$0.11vs$0.10

Q2 24

-83.6%

$0.03vs$0.16

Q4 24

-5.5%

$0.16vs$0.17

Q2 25

+75.1%

$0.35vs$0.20

Q4 25

-38.6%

$0.12vs$0.20

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 25, 2026	—	—	—	—
Q4 2025	Nov 25, 2025	$0.20	$0.12	-38.6%	✗ MISS
Q2 2025	May 27, 2025	$0.20	$0.35	+75.1%	✓ BEAT
Q4 2024	Nov 27, 2024	$0.17	$0.16	-5.5%	✗ MISS
Q2 2024	May 28, 2024	$0.16	$0.03	-83.6%	✗ MISS
Q3 2023	Sep 29, 2023	$0.10	$0.11	+4.3%	✓ BEAT
Q1 2023	Mar 31, 2023	$0.16	$0.17	+0.9%	✓ BEAT
Q3 2022	Sep 29, 2022	$0.09	$0.09	+5.2%	✓ BEAT
Q1 2022	Mar 31, 2022	$0.18	$0.19	+4.0%	✓ BEAT
Q3 2021	Sep 30, 2021	$0.25	$0.26	+7.9%	✓ BEAT
Q1 2021	Mar 31, 2021	$0.37	$0.36	-3.1%	✗ MISS
Q3 2020	Sep 30, 2020	$0.22	$0.26	+15.3%	✓ BEAT
Q1 2020	Mar 31, 2020	$0.16	$0.17	+4.6%	✓ BEAT
Q3 2019	Sep 30, 2019	—	$0.13	—	—
Q1 2019	Mar 31, 2019	—	$0.13	—	—
Q3 2018	Sep 30, 2018	—	$0.10	—	—
Q1 2018	Mar 31, 2018	—	$0.13	—	—
Q3 2017	Sep 30, 2017	—	$0.09	—	—
Q1 2017	Mar 31, 2017	—	$0.10	—	—
Q3 2016	Sep 30, 2016	—	$0.09	—	—

Frequently Asked Questions about FSPKF

What is FSPKF's current stock price?

Fisher & Paykel Healthcare Corporation Limited (FSPKF) is currently trading at $21.92 per share. The stock has moved -8.67% today.

What is the analyst price target for FSPKF?

The average analyst price target for FSPKF is $23.43, based on 1 analyst.

What sector is Fisher & Paykel Healthcare Corporation Limited in?

Fisher & Paykel Healthcare Corporation Limited operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.

What is FSPKF's market cap?

Fisher & Paykel Healthcare Corporation Limited has a market capitalization of $12.85 billion, making it a large-cap company.

Does FSPKF pay dividends?

No, Fisher & Paykel Healthcare Corporation Limited does not currently pay a dividend to shareholders.